NewAmsterdam Pharma Company N.V.NAMSNASDAQ
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank26
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Percentile
P26
Within normal range
vs 3Y Ago
0x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
PeriodValue
Q4 2025-24.88%
Q3 202513.10%
Q2 2025-3.49%
Q1 20252.67%
Q4 2024-198.04%
Q3 202476.79%
Q2 20241.45%
Q1 2024-66.24%
Q4 20236.38%
Q3 2023-20.54%
Q2 20238.03%
Q1 2023-209.60%
Q4 202212221.36%
Q3 2022-38.99%
Q2 202256.16%
Q1 2022-166.60%
Q4 2021484.07%
Q3 202158.75%
Q2 2021-84.30%
Q1 202186.46%
Q4 20200.00%
Q3 20200.00%
Q2 20200.00%
Q1 20200.00%